These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33955570)

  • 21. Risk factors and anti-HBc reactivity among first time blood donors.
    Molijn MH; van der Linden JM; Ko LK; Gorgels J; Hop W; van Rhenen DJ
    Vox Sang; 1997; 72(4):207-10. PubMed ID: 9228709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HBc and hepatitis B virus DNA among HBsAg-negative blood donors from the main central blood bank units in Eastern Libya.
    El-Nabi SH; El-Garawani I; Ismail F; Abdelsameea E
    Transfus Med; 2020 Oct; 30(5):401-405. PubMed ID: 32894893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study.
    Ogunfemi MK; Olawumi HO; Olokoba AB; Kagu MB; Biliaminu SA; Durowade KA; Durotoye IA; Shittu AO
    Malawi Med J; 2017 Mar; 29(1):32-36. PubMed ID: 28567194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of HBV infection, detection of subgenotypes F1b, A2, and D4, and differential risk factors among Mexican risk populations with low socioeconomic status.
    Jose-Abrego A; Panduro A; Fierro NA; Roman S
    J Med Virol; 2017 Dec; 89(12):2149-2157. PubMed ID: 28792071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and risk factors of hepatitis B virus infection in Middle-Limburg Belgium, year 2017: Importance of migration.
    Koc ÖM; Kremer C; Bielen R; Buscchots D; Hens N; Nevens F; Robaeys G
    J Med Virol; 2019 Aug; 91(8):1479-1488. PubMed ID: 30870580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Hepatitis B Virus (HBV) Among Blood Donors in Eastern Saudi Arabia: Results From a Five-Year Retrospective Study of HBV Seromarkers.
    Alzahrani FM; Muzaheed ; Shaikh SS; Alomar AI; Acharya S; Elhadi N
    Ann Lab Med; 2019 Jan; 39(1):81-85. PubMed ID: 30215234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide.
    Tang X; Allain JP; Wang H; Rong X; Chen J; Huang K; Xu R; Wang M; Huang J; Liao Q; Shan Z; Luo S; Li T; Li C; Fu Y
    J Viral Hepat; 2018 Sep; 25(9):1008-1016. PubMed ID: 29624818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibodies against hepatitis B virus core antigen among blood donors].
    Moncharmont P; Bourgeot C; Papon S; Duraffourg M
    Transfus Clin Biol; 2000 Feb; 7(1):63-9. PubMed ID: 10730347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing.
    Miletić M; Bingulac-Popović J; Stojić Vidović M; Hećimović A; Berendika M; Babić I; Đogić V; Samardžija M; Barišić K; Jukić I; Mihaljević I
    Transfus Clin Biol; 2019 Nov; 26(4):257-262. PubMed ID: 31153786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C; Offergeld R
    Vox Sang; 2019 Jul; 114(5):459-466. PubMed ID: 30968958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.